Cordycepin (Cordyceps militaris) — genome-discovered natural product dossier
A genotype→chemotype prediction from the engine's fungal-BGC caller: it identifies the Cns1–4 cluster in the Cordyceps militaris genome and predicts cordycepin as the product. Cordycepin is a known, off-patent natural product — this dossier is the COMPUTATIONAL prediction of what the genome can make, PENDING WET-LAB confirmation (ferment, isolate, confirm by HPLC vs an authentic cordycepin standard).
Research intelligence — a ranked, filtered hypothesis, not a validated cure. No disease or efficacy claim. Computational transcriptomic prediction, pending wet-lab.
Genome → BGC (Cns1–4) → cordycepin · computational prediction, pending wet-lab · public off-patent natural product · a genotype→chemotype teaching case
Same mechanism or overlapping tags. Computational, pending wet-lab.
Unlock the full dossier on the Exchange.
The full dossier — ranked candidate lists, measured-selectivity detail, published-literature corroboration, and known-compound structures — is delivered as a PDF to your checkout email. The teaser and the free academic package above are always public.
Buy this dossier →Provenance: Real artifact: fungal-BGC caller on the Cordyceps militaris genome (cordycepin/pentostatin Cns1–4 cluster; recovered via classify-not-filter). Cordycepin structure is public prior art. Computational genotype→chemotype prediction — PENDING WET-LAB. · Updated 2026-06-27.
Research intelligence, not medical, efficacy, or freedom-to-operate advice. All candidate signals are computational transcriptomic predictions pending wet-lab validation. The subscriber owns development and claims decisions and is responsible for its own freedom-to-operate. CONFIDENTIAL — MightyCloud Collective / OmniRayn Foundry.